7 results
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
Mycobacterium tuberculosis ... infection (TB) ... A and B virus infection ... #OIs #HIVAIDS # ... IDSA #management #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
Mycobacterium tuberculosis ... infection (TB) ... A and B virus infection ... #OIs #HIVAIDS # ... IDSA #management #pharmacology
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
infections/year ... (LTBI) Pathophysiology ... Treatment: Active ... Initiating Treatment ... #Management #Treatment
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
infections/year ... (LTBI) Pathophysiology ... Treatment: Active ... Initiating Treatment ... #Management #Treatment
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
Mycobacterium Tuberculosis ... Infection and Disease ... a person with infectious ... Mycobacterium #Tuberculosis ... #HIVAIDS #pharmacology
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
Individualized Treatment ... Multi-Drug Resistant Tuberculosis ... are contacts of infectious ... MDRTB #management #Treatment ... antimicrobials #regimens #pharmacology
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
Note: Active TB ... Mycobacterium #AviumComplex ... IDSA #Prevention #Treatment ... opportunistic #infections ... #HIVAIDS #pharmacology